Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.

This is a case report of two female patients with severe vaginal bleeding following previous treatment of gynecological malignancies and no pre-existing coagulation factor deficiency. Bleeding was controlled with two and one relatively small doses of rFVIIa, respectively.

– M. Aldouri